Ikeda, Yukio

Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome

Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences

Peroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Cited by 832

High Glucose Induces Transactivation of the .ALPHA.2-HS Glycoprotein Gene Through the ERK1/2 Signaling Pathway

Takata, H., Ikeda, Y., Suehiro, T., Ishibashi, A., Inoue, M., Kumon, Y., & Terada, Y. (2009) · Journal of Atherosclerosis and Thrombosis

Adipokines, Inflammation, and Metabolic DiseasesAdvanced Glycation End Products research

Cited by 66

Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study

NOMURA, T., IKEDA, Y., NAKAO, S., ITO, K., ISHIDA, K., SUEHIRO, T., & HASHIMOTO, K. (2007) · Endocrine Journal

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 61

Comparative Study of Different Iron-Chelating Agents in Cold-Induced Brain Edema

Ikeda, Y., Ikeda, K., & Long, D. M. (1989) · Neurosurgery

Barrier Structure and Function StudiesTraumatic Brain Injury and Neurovascular Disturbances

Cited by 38

Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance

Arii, K., Ota, K., Suehiro, T., Ikeda, Y., Nishimura, K., Kumon, Y., & Hashimoto, K. (2005) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 15

Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal‐S

Onishi, Y., Niemoeller, E., Ikeda, Y., Takagi, H., Yabe, D., & Seino, Y. (2015) · Journal of Diabetes Investigation

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 13